Skip to Content
Authors Abbott DE, Baker MS, Talamonti MS
Author Profile(s)
Journal J Surg Oncol Volume: 101 Issue: 4 Pages: 315-20
Publish Date 2010 Mar 15
PubMed ID 20187063

The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions. Copyright © 2016 The Board of Regents of the University of Wisconsin System